Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the microfluidics market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[183 Pages Report] The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.

Microfluidics Market
To learn more about this report, request a free PDF copy

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

Regional Insights

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Microfluidics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • Potential Applications of Drug Delivery using Microfluidics
  • Market Restraints
    • Complicated and Time-Consuming Regulatory Approval Process
  • Market Opportunities
    • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
    • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
  • Market Challenges
    • Integration of Microfluidics with Existing Workflows
Market Segmentation Analysis
  • Material: Increasing use of glass and silicon-based materials for microfluidic devices

    Glass is preferred for microfluidic devices due to its excellent optical transparency properties, high chemical resistance, and biocompatibility. Polymer-based microfluidic devices offer advantages such as lower manufacturing costs, ease of fabrication through techniques, and flexibility in design. Silicon is widely used in microelectronics and is ideal for integrating sensors, actuators, and other microelectromechanical systems (MEMS) components. Silicon-based microfluidics offer advantages such as high dimensional accuracy, low surface roughness, and compatibility with standard semiconductor fabrication processes.

  • Component: Adoption of microneedles and pumps for minimal risk of infection

    Microneedles are minimally invasive devices for various medical applications such as drug delivery, vaccination, and diagnostics. The need-based preference for microneedles is driven by painless drug administration, minimal risk of infection, and reduced tissue damage compared to traditional hypodermic needles. Micropumps are essential in microfluidics, enabling fluid transportation, metering, and mixing at the microscale. Microfluidic chips are the backbone of microfluidic systems, enabling the integration of various components to perform complex fluid manipulation tasks.

  • Application: Significant application of microfluidic devices in IVD and therapeutics

    In-vitro diagnostics (IVD) play a crucial role in healthcare systems by providing information for disease detection, prevention, and management. Microfluidics has revolutionized IVD by enabling rapid analyses and enhanced sensitivity in diagnostic assays with its ability to manipulate small volumes of fluid. Microfluidics has immense potential to streamline pharmaceutical and life science research processes such as drug discovery, cell biology studies, genomics/proteomics analysis, and synthetic biology applications. The advantages of using microfluidic platforms are reduced reagent consumption, faster reaction times, precise control over experimental conditions, and integration of multiple functionalities on a single chip/platform. Microfluidics holds significant potential to revolutionize therapeutics through innovations in drug delivery systems, personalized medicine, regenerative medicine, and tissue engineering. The ability to specifically control fluid flow at the microscale enables the development of novel therapeutic solutions targeting specific cells or tissues, reducing side effects associated with systemic administration.

  • End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers

    Academic institutions and research organizations rely on microfluidics to conduct biosciences, material sciences, and chemical engineering experiments. These end users require precise control over fluids, high reproducibility of results, and reduced sample volume consumption. Hospitals and diagnostic facilities benefit from microfluidic technology through point-of-care (POC) diagnostics requiring rapid analysis of biomarkers or other analytes in body fluids. Microfluidics is revolutionizing drug development and manufacturing processes within the pharmaceutical and biotechnology industries.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Microfluidics Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Microfluidics Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Microfluidics Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Microfluidics Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Microfluidics Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Microfluidics Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Microfluidics Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Microfluidics Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Microfluidics Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Microfluidics Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Microfluidics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform

    Astraveus SAS, an innovator in cell and gene therapy (CGT) manufacturing, has emerged from stealth with USD 18.26 million Series Seed financing. The funding round was led by AdBio Partners, co-syndicated with M Ventures, Johnson & Johnson Innovation – JJDC Inc., and Bpifrance Large Venture. Astraveus leverages microfluidic cell foundries known as the Lakhesys platform to enhance CGT manufacturing processes. The Lakhesys system employs deep process optimization and single-use microfluidic bioprocessors to optimize CGT outcomes while minimizing resource utilization. [Published On: 2023-07-27]

  • Bio-Techne to acquire Swiss spatial biology firm Lunaphore

    Bio-Techne, a major player in microfluidics, announced its recent acquisition of Lunaphore, a Swiss-based developer of automated spatial biology products. Lunaphore's microfluidic technology offers precise and hyper plex proteomic and transcriptomic biomarkers for tumors and other tissues. This innovative technology provides the necessary data for discovering and developing diagnostic tools in the fields of immunology, immuno-oncology, and neuroscience. By leveraging Lunaphore's advanced solutions, Bio-Techne aims further to advance research and development in these critical areas. [Published On: 2023-06-22]

  • CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

    CellFE Inc., a microfluidics company, launched its Infinity Mtx cellular engineering platform for commercial use. This platform utilizes rapid cell compression and re-expansion techniques to introduce target payloads into cells effectively. The advantages of this platform are that it yields high quantities of edited cells, reduces recovery and expansion times, facilitates efficient uptake of various payloads, and lowers manufacturing expenses. By leveraging these capabilities, CellFE Inc. aims to revolutionize the field of cell therapy and contribute to the development of innovative treatments. [Published On: 2023-05-10]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Microfluidics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc..

Microfluidics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Material
    • Glass-based
    • Polymer-based
    • Silicon-based
  • Component
    • Micro Needle
    • Micro Pump
    • Microfluidic Chip
  • Application
    • In-Vitro Diagnostics
      • Clinical Diagnostics
      • Point-Of-Care Testing
      • Veterinary Diagnostics
    • Pharmaceutical & Life Science Research
      • Lab Analytics
        • Capillary Electrophoresis
        • Cell-based Assays
        • Genomic analysis
        • Proteomic Analysis
      • Microdispensing
      • Microreaction
    • Therapeutics
      • Drug Delivery
      • Wearable Devices
  • End User
    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Microfluidics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Microfluidics Market, by Material
  7. Microfluidics Market, by Component
  8. Microfluidics Market, by Application
  9. Microfluidics Market, by End User
  10. Americas Microfluidics Market
  11. Asia-Pacific Microfluidics Market
  12. Europe, Middle East & Africa Microfluidics Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 736]
  17. List of Companies Mentioned [Total: 30]
The Scope of Microfluidics in Organ-on-a-Chip Technology
October 6, 2023
The Scope of Microfluidics in Organ-on-a-Chip Technology
As the field of biomedical engineering continues to expand, there is an increasing need for more realistic and predictive in vitro models that can replicate the complex physiological responses of living tissues and organs. This is where microfluidics technology comes in, offering precise control over the micro-environmental conditions within a 3D cell culture system. This blog post dives into the scope of microfluidics technology in organ-on-a-chip devices.

Organ-on-a-chip devices are microfluidic-based systems that aim to mimic the physiological functions and responses of real organs in vitro. These devices are composed of a chip-scale platform that houses microfluidic channels, interconnected chambers, and culture wells. The microfluidic channels are designed to mimic the complex microvascular network of the target organ, while the culture wells provide a supportive environment for living cells. Together, these components allow for the precise control of the chemical and mechanical cues that cells receive within a 3D environment.

The scope of microfluidics technology in organ-on-a-chip devices is widespread. Researchers are exploring the use of these devices for drug discovery, toxicity testing, disease modeling, and even personalized medicine. For example, a liver-on-a-chip device can be used to evaluate the toxicity of new drugs before they are tested in animals or humans. Similarly, a lung-on-a-chip device can be used to study the effects of environmental pollutants on lung function and response.

One of the primary advantages of microfluidics technology is that it creates customized and complex microenvironments that are not possible with conventional cell cultures. For example, researchers can mimic the shear stress and fluid flow conditions found in the heart or blood vessels to study cardiovascular disease. Similarly, microfluidics technology can create a gradient of chemicals or growth factors to study cell migration and cell-cell interactions.

In addition to its applications in organ-on-a-chip devices, microfluidics technology has also revolutionized other fields, such as lab-on-a-chip and point-of-care diagnostics. These applications use the same principles of precise fluid control and manipulation to perform complex chemical and biological assays in a miniaturized format. For example, a resource-limited setting could benefit from a portable diagnostic tool that uses microfluidics technology to detect infectious diseases or biomarkers.

The scope of microfluidics technology in organ-on-a-chip devices is vast and continues to expand with advancements in engineering and biology. As researchers continue to refine these devices, they have the potential to revolutionize the way we study and treat diseases. Microfluidic-based systems have the ability to create complex in vitro models that accurately replicate the physiological responses of living tissues and organs, allowing for more predictive drug discovery, disease modeling, and personalized medicine. With further development and integration of these technologies, we may one day have a suite of organ-on-a-chip devices that can be tailored to individual patients and used to develop personalized treatments.

Frequently Asked Questions
  1. How big is the Microfluidics Market?
    Ans. The Global Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024.
  2. What is the Microfluidics Market growth?
    Ans. The Global Microfluidics Market to grow USD 124.31 billion by 2030, at a CAGR of 25.37%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.